BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12784544)

  • 1. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison].
    Wurglics M; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(3):236-41. PubMed ID: 12784544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formulation of St. John's wort extract. A medicinal obstacle course].
    Schmidt PC
    Pharm Unserer Zeit; 2003; 32(3):203-11. PubMed ID: 12784540
    [No Abstract]   [Full Text] [Related]  

  • 3. Batch-to-batch reproducibility of St. John's wort preparations.
    Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. John's Wort: is it effective and harmless?
    Biron CR
    RDH; 1999 Jun; 19(6):74-6. PubMed ID: 10895712
    [No Abstract]   [Full Text] [Related]  

  • 6. Variability in St. John's wort formulations is an important consideration.
    Kroll DJ; Shaw HS; Wall ME; Oberlies NH
    Altern Ther Health Med; 2001; 7(6):21-2. PubMed ID: 11712467
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of dynamic accumulation of secondary metabolites in three subspecies of Hypericum perforatum.
    Filippini R; Piovan A; Borsarini A; Caniato R
    Fitoterapia; 2010 Mar; 81(2):115-9. PubMed ID: 19686808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
    [No Abstract]   [Full Text] [Related]  

  • 12. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V; Schmidt M
    Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biorelevant dissolution testing of St John's wort products.
    Westerhoff K; Kaunzinger A; Wurglics M; Dressman J; Schubert-Zsilavecz M
    J Pharm Pharmacol; 2002 Dec; 54(12):1615-21. PubMed ID: 12542890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
    Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
    J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperforin in St. John's wort--drug, extraction and preparations].
    Lang F; Biber A; Erdelmeier C
    Pharm Unserer Zeit; 2002; 31(5):512-4. PubMed ID: 12369170
    [No Abstract]   [Full Text] [Related]  

  • 16. St John's wort: Prozac from the plant kingdom.
    Di Carlo G; Borrelli F; Ernst E; Izzo AA
    Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
    Weber CC; Kressmann S; Fricker G; Müller WE
    Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
    Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
    Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.